SCHEMBL19957271

SCHEMBL19957271

C=C(/C=C(\CC)NCCC)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19957100 0.83 ALDH1A1 (0.33)
SCHEMBL19957251 0.78
SCHEMBL23825290 0.71 MMP1 (0.39)
SCHEMBL23825418 0.71 MMP1 (0.39)
SCHEMBL23825415 0.71 MMP1 (0.39)
SCHEMBL23825292 0.71 MMP1 (0.39)
SCHEMBL16844295 0.71
Hydrochloric Acid SCHEMBL22575223 0.69 MMP1 (0.34)
Hydrochloric Acid SCHEMBL22575224 0.69 MMP1 (0.34)
SCHEMBL23157811 0.68 ZDHHC20 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188778-A1 NOVEL POLYMORPHS OF 4-[3-CHLORO-4-(N'-CYCLOPROPYL UREIDO)PHENOXY]-7-METHOXYQUINOLINE-6-CARBOXAMIDE, ITS SALTS AND PROCESS FOR THE PREPARATION THEREOF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2021-06-24 US disclosed
EP-3293177-A1 TYROSINE KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-03-14 EP disclosed